Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 16601077)

Published in Stem Cells on April 06, 2006

Authors

Sanjay Sinha1, Brian R Wamhoff, Mark H Hoofnagle, James Thomas, Ronald L Neppl, Thomas Deering, Brian P Helmke, Douglas K Bowles, Avril V Somlyo, Gary K Owens

Author Affiliations

1: Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, 22908-0736, USA.

Articles citing this

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature (2009) 10.26

Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest (2006) 1.47

Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation. J Cell Biol (2008) 1.14

Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes. Am J Physiol Heart Circ Physiol (2011) 1.10

A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev (2009) 1.09

Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells. Tissue Eng Part A (2010) 1.07

Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds. Biomaterials (2011) 0.96

The actin-associated protein Palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies. J Biol Chem (2008) 0.94

The actin associated protein palladin is important for the early smooth muscle cell differentiation. PLoS One (2010) 0.93

Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol (2011) 0.90

The actin associated protein palladin in smooth muscle and in the development of diseases of the cardiovasculature and in cancer. J Muscle Res Cell Motil (2011) 0.87

WD repeat-containing protein 5, a ubiquitously expressed histone methyltransferase adaptor protein, regulates smooth muscle cell-selective gene activation through interaction with pituitary homeobox 2. J Biol Chem (2011) 0.86

Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells. Development (2015) 0.83

Sodium butyrate promotes the differentiation of rat bone marrow mesenchymal stem cells to smooth muscle cells through histone acetylation. PLoS One (2014) 0.80

Construction of vascular tissues with macro-porous nano-fibrous scaffolds and smooth muscle cells enriched from differentiated embryonic stem cells. PLoS One (2012) 0.80

Transdifferentiation of human endothelial progenitors into smooth muscle cells. Biomaterials (2016) 0.79

Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environments. Tissue Eng Part A (2012) 0.79

Xeno-free culture of human spermatogonial stem cells supported by human embryonic stem cell-derived fibroblast-like cells. Asian J Androl (2009) 0.78

Purification and functional assessment of smooth muscle cells derived from mouse embryonic stem cells. J Geriatr Cardiol (2013) 0.75

TGF-β1-induced differentiation of SHED into functional smooth muscle cells. Stem Cell Res Ther (2017) 0.75

Articles by these authors

Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev (2003) 9.32

Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol (2009) 4.69

NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol (2006) 4.27

Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res (2003) 3.99

Mechanisms of mechanotransduction. Dev Cell (2006) 3.95

Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69

A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res (2014) 3.49

NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37

Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol (2006) 3.31

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation (2005) 3.12

Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem (2004) 2.94

Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA (2007) 2.84

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol (2008) 2.74

Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA (2008) 2.67

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A (2007) 2.60

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol (2005) 2.56

Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res (2007) 2.55

Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res (2005) 2.45

Clarifying differences between review designs and methods. Syst Rev (2012) 2.39

Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat Genet (2002) 2.39

Molecular determinants of vascular smooth muscle cell diversity. Circ Res (2005) 2.33

Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev (2013) 2.33

Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res (2008) 2.30

Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res (2012) 2.28

Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18

3D echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr (2007) 2.12

Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler Thromb Vasc Biol (2004) 2.09

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res (2010) 2.04

Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest (2006) 2.04

Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res (2007) 2.00

Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol (2011) 1.98

Mapping the dynamics of shear stress-induced structural changes in endothelial cells. Am J Physiol Cell Physiol (2007) 1.98

Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol (2004) 1.93

Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol (2006) 1.91

Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells (2006) 1.80

Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res (2009) 1.78

Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ Res (2007) 1.76

Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest (2011) 1.70

Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol (2007) 1.70

Excitation-transcription coupling in arterial smooth muscle. Circ Res (2006) 1.70

PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol (2006) 1.65

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain (2009) 1.64

Programming smooth muscle plasticity with chromatin dynamics. Circ Res (2007) 1.63

5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest (2005) 1.62

A call for full public disclosure and moratorium on donation after cardiac death in children. Pediatr Crit Care Med (2010) 1.54

Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53

Systematic reviews and their application to research in speech and language therapy: a response to T. R. Pring's 'Ask a silly question: two decades of troublesome trials' (2004). Int J Lang Commun Disord (2005) 1.51

Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension (2005) 1.49

Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol (2008) 1.46

Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods (2013) 1.46

The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle. Structure (2004) 1.45

Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol (2006) 1.44

Measurements of methane emissions at natural gas production sites in the United States. Proc Natl Acad Sci U S A (2013) 1.44

Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol (2003) 1.42

Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J Biol Chem (2009) 1.42

Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol (2004) 1.40

Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.37

Loss of PECAM-1 function impairs alveolarization. J Biol Chem (2005) 1.35

Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction. J Biol Chem (2009) 1.32

Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol (2009) 1.32

Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors. J Med Chem (2010) 1.28

RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem (2002) 1.25

DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev (2011) 1.25

Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res (2009) 1.23

Developing evidence-based recommendations in public health--incorporating the views of practitioners, service users and user representatives. Health Expect (2008) 1.23

Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23

Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg (2008) 1.19

Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles. J Vasc Res (2009) 1.19

A BEME systematic review of UK undergraduate medical education in the general practice setting: BEME Guide No. 32. Med Teach (2015) 1.18

Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem (2002) 1.17

Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol (2006) 1.17

Rho-kinase: regulation, (dys)function, and inhibition. Biol Chem (2013) 1.17

Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res (2004) 1.15

Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am J Physiol Cell Physiol (2011) 1.15

Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.15

Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflammation (2014) 1.15

Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+). Am J Physiol Endocrinol Metab (2002) 1.14

Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation. J Cell Biol (2008) 1.14

Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol (2006) 1.13

The histone methyltransferase Set7/9 promotes myoblast differentiation and myofibril assembly. J Cell Biol (2011) 1.13

Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circ Res (2003) 1.13

Is consumer response to plain/standardised tobacco packaging consistent with framework convention on tobacco control guidelines? A systematic review of quantitative studies. PLoS One (2013) 1.13

The conservative management of interstitial pregnancy. BJOG (2004) 1.13

Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol (2012) 1.12